Dabalos, Luzviena T.

HRN: 28-69-94  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/17/2026
03/24/2026
IV
500mg
BID
TYPHOID FEVER, INTRA ABDOMINAL INFECTION
Remove - Pending Acceptance
03/17/2026
CEFTRIAXONE 1G (VIAL)
03/17/2026
03/24/2026
IV
1G
BID
TYPHOID FEVER
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: